HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David G Harrison Selected Research

Xanthine Oxidase

2/2006Coronary artery superoxide production and nox isoform expression in human coronary artery disease.
12/2002Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David G Harrison Research Topics

Disease

86Hypertension (High Blood Pressure)
01/2022 - 08/2002
38Inflammation (Inflammations)
01/2021 - 09/2003
22Atherosclerosis
01/2022 - 01/2002
11Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 08/2002
11Vascular Diseases (Vascular Disease)
01/2018 - 11/2002
5Heart Failure
01/2021 - 05/2002
5Coronary Artery Disease (Coronary Atherosclerosis)
03/2016 - 03/2003
4Essential Hypertension
01/2022 - 08/2017
4Fibrosis (Cirrhosis)
01/2022 - 03/2015
3Necrosis
01/2021 - 03/2015
3Atrial Fibrillation
06/2020 - 11/2002
3Hypertrophy
01/2020 - 09/2003
3Thrombosis (Thrombus)
01/2020 - 11/2002
3Neoplasms (Cancer)
01/2018 - 10/2005
3Vascular Remodeling
12/2014 - 01/2013
3Atherosclerotic Plaque (Atheroma)
06/2010 - 02/2004
3Coronary Disease (Coronary Heart Disease)
05/2010 - 03/2003
2Periodontitis
11/2021 - 01/2019
2Myocardial Infarction
01/2020 - 03/2011
2Insulin Resistance
07/2017 - 03/2009
2Hypoxia (Hypoxemia)
12/2014 - 02/2004
2Weight Gain
07/2014 - 07/2011
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
03/2014 - 01/2014
2Pathologic Processes
01/2014 - 11/2011
2Type 2 Diabetes Mellitus (MODY)
01/2014 - 05/2007
1Breast Neoplasms (Breast Cancer)
01/2022

Drug/Important Bio-Agent (IBA)

48Angiotensin IIIBA
12/2020 - 10/2002
24Superoxides (Superoxide)IBA
12/2020 - 08/2002
23Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 08/2002
21SaltsIBA
01/2020 - 04/2003
19CytokinesIBA
01/2022 - 06/2003
18NADPH Oxidases (NAD(P)H oxidase)IBA
01/2019 - 03/2003
12SodiumIBA
01/2022 - 11/2008
10Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2020 - 08/2002
10EnzymesIBA
01/2018 - 08/2002
9Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2003
9Superoxide DismutaseIBA
01/2020 - 08/2002
9Interleukin-17 (Interleukin 17)IBA
07/2017 - 02/2010
8Desoxycorticosterone Acetate (DOCA)FDA Link
07/2017 - 04/2003
7AntioxidantsIBA
06/2020 - 01/2007
6isolevuglandinIBA
01/2022 - 10/2017
6Interleukin-6 (Interleukin 6)IBA
01/2018 - 05/2010
64- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
01/2016 - 10/2002
6Oxidants (Oxidizing Agents)IBA
01/2016 - 06/2003
5Acetates (Acetic Acid Esters)FDA Link
01/2020 - 04/2003
5Desoxycorticosterone (Deoxycorticosterone)IBA
01/2020 - 04/2003
5CatalaseIBA
01/2019 - 04/2003
5Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2018 - 04/2003
5AngiotensinsIBA
05/2016 - 12/2006
5CollagenIBA
05/2016 - 02/2014
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 10/2007
5Norepinephrine (Noradrenaline)FDA LinkGeneric
08/2015 - 11/2008
5Nitric Oxide Synthase (NO Synthase)IBA
11/2011 - 11/2002
4Oxidoreductases (Dehydrogenase)IBA
01/2019 - 09/2003
4NADP (NADPH)IBA
01/2019 - 08/2005
4sapropterin (tetrahydrobiopterin)FDA Link
01/2018 - 04/2003
4InterferonsIBA
04/2016 - 07/2013
3AntigensIBA
01/2021 - 05/2015
3Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2006
3Sirtuin 3IBA
12/2020 - 08/2017
3LipidsIBA
06/2020 - 08/2008
3C-Reactive ProteinIBA
01/2020 - 01/2005
3Phosphotransferases (Kinase)IBA
01/2019 - 09/2003
3Glucose (Dextrose)FDA LinkGeneric
10/2018 - 03/2016
3Oxygen (Dioxygen)IBA
01/2018 - 01/2007
3tempolIBA
01/2016 - 05/2007
3Protein Isoforms (Isoforms)IBA
07/2011 - 09/2002
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2021 - 11/2014
2InterleukinsIBA
01/2021 - 01/2018
2InflammasomesIBA
01/2020 - 01/2018
2Amiloride (Midamor)FDA LinkGeneric
01/2019 - 10/2017
2Messenger RNA (mRNA)IBA
01/2018 - 01/2018
2LigandsIBA
01/2018 - 12/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018 - 06/2003
2GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA
01/2018 - 01/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 02/2004
2NitrogenIBA
01/2018 - 01/2007
2ebselenIBA
08/2017 - 01/2005
2MitoTEMPOIBA
08/2017 - 07/2010
2LeptinIBA
07/2017 - 07/2014
2NG-Nitroarginine Methyl Ester (L-NAME)IBA
04/2016 - 10/2015
2Hydralazine (Apresoline)FDA LinkGeneric
01/2016 - 07/2010
2AngiotensinogenIBA
06/2015 - 03/2015
2Recombinases (Recombinase)IBA
03/2014 - 01/2014
2Tyrosine (L-Tyrosine)FDA Link
07/2013 - 09/2003
2acetovanillone (apocynin)IBA
06/2012 - 03/2009
2Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA
06/2012 - 01/2010
2ApolipoproteinsIBA
07/2011 - 06/2010
2Peroxynitrous Acid (Peroxynitrite)IBA
11/2009 - 02/2008
2Hormones (Hormone)IBA
11/2008 - 12/2006
2Glutathione (Reduced Glutathione)IBA
04/2007 - 03/2006
2multidrug resistance-associated protein 1IBA
04/2007 - 09/2005
2Glutathione Disulfide (GSSG)FDA LinkGeneric
04/2007 - 03/2006
2Xanthine OxidaseIBA
02/2006 - 12/2002
2XanthineIBA
08/2005 - 03/2003
2Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2002 - 01/2002
1efavirenz (Sustiva)FDA Link
01/2022
1Docetaxel (Taxotere)FDA Link
01/2022

Therapy/Procedure

8Therapeutics
01/2022 - 11/2012
2Ligation
07/2011 - 06/2010